Budesonide CIR capsules (once or twice daily divided-dose) in active Crohn's disease: a randomized placebo-controlled study in the United States.

Source:http://linkedlifedata.com/resource/pubmed/id/12135030

Download in:

View as

General Info

PMID
12135030